|
業務類別
|
-- |
|
業務概覽
|
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing. |
| 公司地址
| Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ |
| 電話號碼
| +44 8450347900 |
| 傳真號碼
| +44 8450347901 |
| 公司網頁
| https://www.nanoporetech.com |
| 員工數量
| 1315 |
| Mr. Nicholas Patrick Keher |
Executive Director,Chief Financial Officer |
英鎊 402.46K |
02/03/2026 |
| Ms. Hannah Laura Coote |
Company Secretary |
-- |
02/03/2026 |
| Mr. Francis Van Parys |
Executive Director,Chief Executive Officer |
-- |
02/03/2026 |
|
|
| Mr. John O'Higgins |
Non-Executive Director |
27/02/2026 |
| Dr. Daniel Mahony |
Non-Executive Director |
02/03/2026 |
| Mr. Nicholas Patrick Keher |
Executive Director,Chief Financial Officer |
02/03/2026 |
| Mr. Adrian Nevil Hennah |
Non-Executive Director |
02/03/2026 |
| Mr. Francis Van Parys |
Executive Director,Chief Executive Officer |
02/03/2026 |
| Dr. Heather Elizabeth Preston, M.D. |
Non-Executive Director |
02/03/2026 |
| Ms. Sarah Fortune |
Non-Executive Director |
02/03/2026 |
| Ms. Katherine Sophie Priestman |
Non-Executive Director,Senior Independent Director |
02/03/2026 |
| Mr. Duncan Eden Tatton-Brown |
Non-Executive Director,Chairman |
02/03/2026 |
|
|
|
|
